Blood DNA methylation biomarkers for cognitive decline in older adults with type 2 diabetes

Sigalit Manzali, Ramit Ravona‐Springer, Jasmine Jacob‐Hirsch, Anthony Heymann, Michal S Beeri, Lior Greenbaum · 2025

Read Blood DNA methylation biomarkers for cognitive decline in older adults with type 2 diabetes by Sigalit Manzali, Ramit Ravona‐Springer, Jasmine Jacob‐Hirsch, Anthony Heymann, Michal S Beeri, Lior Greenbaum (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714884.txt.

Description

Sigalit Manzali and co-authors present a 2025 study of blood marks that may warn of thinking loss in people with type 2 diabetes. Diabetes is a known risk factor for dementia. The team followed older adults with the condition over three years. Some went on to develop dementia, while matched peers stayed sharp. Blood samples from both the start and the end were checked for chemical marks on DNA.

The group that later lost skills showed far more change in those marks over time. Hundreds of sites already differed at the start, before any loss was seen. Many of the genes near those sites play roles in brain health or in swelling and immune response. Other genes help nerve cells send signals and grow. The authors say such early blood marks could one day flag who needs close watch.

Catalog record

CREATORSigalit Manzali, Ramit Ravona‐Springer, Jasmine Jacob‐Hirsch, Anthony Heymann, Michal S Beeri, Lior Greenbaum
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11714884

Browse the full library · About the Tower of Babel